Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis (Q36067517)

12 August 2017

Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis (English)

1 reference

12 August 2017

Hui-Juan Cui

1

1 reference

12 August 2017

Xiao-Lin Tong

2

1 reference

12 August 2017

Ping Li

3

1 reference

12 August 2017

Ying-Xu Hao

4

1 reference

12 August 2017

Xiao-Guang Chen

5

1 reference

12 August 2017

Ai-Guo Li

6

1 reference

12 August 2017

Zhi-Yuan Zhang

7

1 reference

12 August 2017

Jun Duan

8

1 reference

12 August 2017

Min Zhen

9

1 reference

12 August 2017

Bin Zhang

10

1 reference

12 August 2017

Chuan-Jin Hua

11

1 reference

12 August 2017

Yue-Wen Gong

12

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

World Journal of Gastroenterology

12 August 2017

1 reference

12 August 2017

10

1 reference

12 August 2017

11

1 reference

12 August 2017

1652-1655

1 reference

Chlamydia-like and coronavirus-like agents found in dead cases of atypical pneumonia by electron microscopy

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Coronavirus as a possible cause of severe acute respiratory syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: case report

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

A novel coronavirus associated with severe acute respiratory syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

A major outbreak of severe acute respiratory syndrome in Hong Kong

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Identification of severe acute respiratory syndrome in Canada

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Prospective study of combination of interferon-alpha with ribavirin for treatment of chronic hepatitis C in children

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Ribavirin antagonizes the effect of azidothymidine on HIV replication

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Synthesis of 1,2,3-triazolo-carbanucleoside analogues of ribavirin targeting an HCV in replicon.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

SARS treatment: experience from a team in Guangdong, China.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Ribavirin inhibits DNA, RNA, and protein synthesis in PHA-stimulated human peripheral blood mononuclear cells: possible explanation for therapeutic efficacy in patients with chronic HCV infection

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572772

23 September 2018

Identifiers

DOI

10.3748/WJG.V10.I11.1652

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

15162543

1 reference